Terms: = Sarcomas AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
274 results:
1. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract] [Full Text] [Related]
2. Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team.
McCabe C; Wright H; Polson K; Wagner AJ
Orphanet J Rare Dis; 2023 Oct; 18(1):313. PubMed ID: 37805596
[TBL] [Abstract] [Full Text] [Related]
3. [Effects of fucoidan inducing impairment of human osteosarcoma cell 143B and its mechanism].
Wang QQ; Lin Q; Shan WY; Zhang T; Li YR; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):739-744. PubMed ID: 37308428
[No Abstract] [Full Text] [Related]
4. High-dose insulin and dexamethasone combined with radiotherapy in endometrial stromal sarcoma recurring with multiple metastases: A case report.
Liang L; Wang J; Xie J; Xu Y; Zhang L; Liu D; Tong X
Medicine (Baltimore); 2023 Apr; 102(15):e33525. PubMed ID: 37058027
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma.
Lo WL; Huang WH; Yeh CF
In Vivo; 2022; 36(6):2965-2972. PubMed ID: 36309350
[TBL] [Abstract] [Full Text] [Related]
6. [Research on three-dimensional printing technology based on three-dimensional multimodality imaging to assist the operation of malignant bone tumors of limbs].
Fang X; Lei S; Luo Y; Zhou Y; Min L; Zhang W; Tu C; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Jul; 36(7):804-810. PubMed ID: 35848174
[TBL] [Abstract] [Full Text] [Related]
7. DNA Base Pairing-Inspired Supramolecular Nanodrug Camouflaged by Cancer-Cell Membrane for Osteosarcoma treatment.
Fu Y; He G; Liu Z; Wang J; Li M; Zhang Z; Bao Q; Wen J; Zhu X; Zhang C; Zhang W
Small; 2022 Jul; 18(30):e2202337. PubMed ID: 35780479
[TBL] [Abstract] [Full Text] [Related]
8. A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor.
Pantaleo MA; Heinrich MC; Italiano A; Valverde C; Schöffski P; Grignani G; Reyners AKL; Bauer S; Reichardt P; Stark D; Berhanu G; Brandt U; Stefanelli T; Gelderblom H
BMC Cancer; 2022 May; 22(1):511. PubMed ID: 35524239
[TBL] [Abstract] [Full Text] [Related]
9. Morbidity and long-term results in patients with wild and mutant type Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations undergoing colorectal cancer surgery.
Aziret M; Subasi O; Bilir C; Tozlu M; Altıntoprak F; Karaman K; Ercan M; Celebi F
Ann Ital Chir; 2022; 92():65-77. PubMed ID: 35342104
[TBL] [Abstract] [Full Text] [Related]
10. FT-IR Spectral Signature of Sensitive and Multidrug-Resistant Osteosarcoma Cell-Derived Extracellular Nanovesicles.
Perut F; Graziani G; Roncuzzi L; Zini N; Avnet S; Baldini N
Cells; 2022 Feb; 11(5):. PubMed ID: 35269400
[TBL] [Abstract] [Full Text] [Related]
11. Introducing a New Biomarker Named R2*-BOLD-MRI Parameter to Assess treatment Response in Osteosarcoma.
Kim CH; Lee JH; Lee JW; Kim E; Choi SH
J Magn Reson Imaging; 2022 Aug; 56(2):538-546. PubMed ID: 34888987
[TBL] [Abstract] [Full Text] [Related]
12. Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study.
Vincenzi B; Napolitano A; Fiocco M; Mir O; Rutkowski P; Blay JY; Reichardt P; Joensuu H; Fumagalli E; Gennatas S; Hindi N; Nannini M; Spalato Ceruso M; Italiano A; Grignani G; Brunello A; Gasperoni S; De Pas T; Badalamenti G; Pantaleo MA; van Houdt WJ; IJzerman NS; Steeghs N; Gelderblom H; Desar IME; Falkenhorst J; Silletta M; Sbaraglia M; Tonini G; Martin-Broto J; Hohenberger P; Le Cesne A; Jones RL; Dei Tos AP; Gronchi A; Bauer S; Casali PG
Clin Cancer Res; 2022 Apr; 28(8):1672-1679. PubMed ID: 34615721
[TBL] [Abstract] [Full Text] [Related]
13. Cost-minimization analysis of biweekly dosing of cetuximab and FOLFIRI compared with panitumumab and FOLFOX for first-line treatment of patients with KRAS wild-type metastatic colorectal cancer in the United States.
Gathirua-Mwangi WG; Sethi H; Afable MG; Bhattacharyya D; Khan T
J Med Econ; 2021; 24(1):1164-1172. PubMed ID: 34529522
[TBL] [Abstract] [Full Text] [Related]
14. DWI and IVIM Imaging in a Murine Model of Rhabdomyosarcoma: Correlations with Quantitative Histopathologic Features.
Fang S; Yang Y; Chen B; Yin Z; Liu Y; Tao J; Zhang Y; Yuan Y; Wang Q; Wang S
J Magn Reson Imaging; 2022 Jan; 55(1):225-233. PubMed ID: 34240504
[TBL] [Abstract] [Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies.
Bauer S; Demetri GD; Halilovic E; Dummer R; Meille C; Tan DSW; Guerreiro N; Jullion A; Ferretti S; Jeay S; Van Bree L; Hourcade-Potelleret F; Wuerthner JU; Fabre C; Cassier PA
Br J Cancer; 2021 Aug; 125(5):687-698. PubMed ID: 34140638
[TBL] [Abstract] [Full Text] [Related]
16. Trends in ovarian conservation and association with survival in premenopausal patients with stage I leiomyosarcoma.
Sia TY; Huang Y; Gockley A; Melamed A; Khoury-Collado F; St Clair C; Hou JY; Tergas AI; Hershman DL; Wright JD
Gynecol Oncol; 2021 Jun; 161(3):734-740. PubMed ID: 33810881
[TBL] [Abstract] [Full Text] [Related]
17. Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy.
George S; Jones RL; Bauer S; Kang YK; Schöffski P; Eskens F; Mir O; Cassier PA; Serrano C; Tap WD; Trent J; Rutkowski P; Patel S; Chawla SP; Meiri E; Gordon M; Zhou T; Roche M; Heinrich MC; von Mehren M
Oncologist; 2021 Apr; 26(4):e639-e649. PubMed ID: 33453089
[TBL] [Abstract] [Full Text] [Related]
18. Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.
Slomovitz BM; Chelariu-Raicu A; Schmeler KM; Lu KH; Gershenson DM; Wolf J; Coleman RL
Int J Gynecol Cancer; 2020 Nov; 30(11):1733-1737. PubMed ID: 33020204
[TBL] [Abstract] [Full Text] [Related]
19. Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG.
van Houdt WJ; Fiore M; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss D; Gonzalez RJ; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Schrage Y; Cardona K; Pennacchioli E; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria SP; Canter R; Mullen JT; Callegaro D; Fairweather M; Miceli R; Raut CP; Gronchi A; Gladdy RA
Cancer; 2020 Nov; 126(22):4917-4925. PubMed ID: 32797703
[TBL] [Abstract] [Full Text] [Related]
20. Leiomyosarcoma of the inferior vena cava. Our experience and a review of the literature.
Rusu CB; Gorbatâi L; Szatmari L; Koren R; Bungărdean CI; Feciche BO; Bumbuluţ C; Andraş IM; Rahotă R; Telecan T; Coman I; Rath-Wolfson L; Crişan N
Rom J Morphol Embryol; 2020; 61(1):227-233. PubMed ID: 32747914
[TBL] [Abstract] [Full Text] [Related]
[Next]
